Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M202140200 on March 28, 2002

J. Biol. Chem., Vol. 277, Issue 24, 21712-21722, June 14, 2002
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/24/21712    most recent
M202140200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ditzel, H. J.
Right arrow Articles by Jensenius, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ditzel, H. J.
Right arrow Articles by Jensenius, J. C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Cancer-associated Cleavage of Cytokeratin 8/18 Heterotypic Complexes Exposes a Neoepitope in Human Adenocarcinomas*

Henrik J. DitzelDagger §, Merel C. M. StrikDagger , Morten K. Larsen, Antony C. Willis||, Ahmad Waseem**, Karin Kejling, and Jens C. JenseniusDagger Dagger

From the Dagger  Department of Immunology, The Scripps Research Institute, La Jolla, California 92037,  Biomedical Laboratory, University of Southern Denmark, 5000 Odense, Denmark, || MRC Immunochemistry Unit, Department of Biochemistry, University of Oxford, OX1 3QU Oxford, United Kingdom, ** Head and Neck Cancer Research Program, Guys, King's, and St. Thomas' Dental Institute, King's College London, London SE1 9RT, United Kingdom, and the Dagger Dagger  Department of Medical Microbiology and Immunology, University of Aarhus, 8000 Aarhus, Denmark

The intermediate filament network in simple glandular epithelial cells predominantly consists of heterotypic complexes of cytokeratin 8 (K8) and cytokeratin 18 (K18). In contrast to other cytokeratins, K8 and K18 are persistently expressed during malignant transformation, but changes in cell morphology are accompanied by alterations in the intermediate filament network. To study molecular changes, K8 and K18 were purified from surgically removed colon cancer and normal epithelia tissues. Western blotting and amino acid sequencing revealed the presence of abundant K8 and K18 fragments, truncated at the N terminus, from cancerous, but not normal, epithelial cells. The fragmentation pattern indicates proteolysis mediated by several enzymes, including trypsin-like enzymes. The cancer-associated forms of K8 and K18 are specifically recognized by the human antibody, COU-1, cloned from the B cells of a cancer patient. We demonstrate that COU-1 recognizes a unique conformational epitope presented only by a complex between K8 and K18. The epitope is revealed after proteolytic removal of the head domain of either K8 or K18. A large panel of recombinant K8 and K18 fragments, deleted N- or C-terminally, allowed for the localization of the COU-1 epitope to the N-terminal part of the rod domains. Using surface plasmon resonance, the affinity of COU-1 for this epitope was determined to be 109 M-1, i.e. more than 2 orders of magnitude higher than for intact heterotypic K8/K18 complexes. The cellular distribution of truncated K8/K18 heterotypic complexes in viable adenocarcinomas cells was probed using COU-1 showing small fibrillar structures distinct from those of intact K8/K18 complexes. Previously we demonstrated the binding and subsequent internalization of recombinant Fab COU-1 to live cancer cells. We have thus characterized a cancer neoepitope recognized by the humoral immune system. The results have biological as well as clinical implications.


* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence and reprint request should be addressed: Dept. of Immunology, IMM2, The Scripps Research Institute, 10550 N. Torrey Pines Rd., La Jolla, CA 92037. Tel.: 858-784-8157; Fax: 858-784-8360; E-mail: hditzel@scripps.edu.


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
H. Lu, K. L. Knutson, E. Gad, and M. L. Disis
The Tumor Antigen Repertoire Identified in Tumor-Bearing Neu Transgenic Mice Predicts Human Tumor Antigens
Cancer Res., October 1, 2006; 66(19): 9754 - 9761.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
F. Dong, H. Su, Y. Huang, Y. Zhong, and G. Zhong
Cleavage of Host Keratin 8 by a Chlamydia-Secreted Protease
Infect. Immun., July 1, 2004; 72(7): 3863 - 3868.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Seike, T. Kondo, Y. Mori, A. Gemma, S. Kudoh, M. Sakamoto, T. Yamada, and S. Hirohashi
Proteomic Analysis of Intestinal Epithelial Cells Expressing Stabilized {beta}-Catenin
Cancer Res., August 1, 2003; 63(15): 4641 - 4647.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement